In summary, our in vitro data suggest that GluOC accelerates the metastasis of MDA-MB-231 breast cancer cells by promoting ROCK1/MYPT1/MLC2 signalling, and by promoting breast cancer cell proliferation via the ROCK1/JAK2/PIK3CA/AKT signalling pathway. Here, AKT1 is linked to breast cancer.